Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Total revenues	$ 44,999	$ 33,445
Cost and operating expenses:
Cost of sales	2,088	488
Research and development	57,834	54,765
Selling, general, and administrative	33,924	31,449
Total cost and operating expenses	93,846	86,702
Loss from operations	(48,847)	(53,257)
Other income:
Interest and other income, net	3,764	3,648
Total other income, net	3,764	3,648
Net loss	$ (45,083)	$ (49,609)
Net loss per share—diluted (in dollars per share)	$ (0.52)	$ (0.60)
Net loss per share—basic (in dollars per share)	$ (0.52)	$ (0.60)
Weighted average common shares outstanding—diluted (in shares)	87,388,106	82,676,624
Weighted average common shares outstanding—basic (in shares)	87,388,106	82,676,624
Comprehensive loss:
Net loss	$ (45,083)	$ (49,609)
Other comprehensive income (loss):
Unrealized gains (losses) on marketable securities	(206)	709
Currency translation adjustment	(273)	93
Total other comprehensive income (loss)	(479)	802
Total comprehensive loss	(45,562)	(48,807)
Share-based compensation expense	10,174	12,514
Product revenues, net
Total revenues	42,550	33,222
Collaboration revenues
Total revenues	$ 2,449	$ 223